Frequencies of TFH and skewing to TFH1 were significantly elevated in high risk CLL (Rai 3-4) relative to low risk CLL (Rai 0) and CD38+ CLL patients showed more TFH1 skewing than CD38- patients (Figure 2B). This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.